Introduction

Breast cancer remains one of the most common malignancies among women worldwide. Early detection and accurate staging play a crucial role in treatment planning and improving patient outcomes. F-18 FDG PET-CT scan has emerged as a powerful diagnostic tool that not only detects the primary tumor but also identifies nodal and distant metastases in a single whole-body evaluation.

This case demonstrates how FDG PET-CT changed the staging and management plan of a breast cancer patient, emphasizing its value as a one-stop solution in oncology.

Case Presentation

Patient: 60-year-old female

History: Lump in the right breast for 3 months

Initial Investigation: Bilateral mammography revealed BIRADS V lesion in the right breast, highly suspicious for malignancy.

 

PET-CT Findings

The patient underwent whole-body FDG PET-CT, which showed:

FDG-avid primary mass in the right breast

Metastatic spread to multiple lymph nodes, lung, and bones

Based on these findings, the stage of cancer changed, which directly altered the treatment plan

 

 

Impact on Treatment

The PET-CT scan redefined the staging, allowing oncologists to personalize therapy.

Instead of local treatment alone, systemic therapy was initiated.

This highlights how PET-CT functions as a “metabolic biopsy”, providing crucial insights beyond anatomical imaging.

Unique Value at NeuMoD PET-CT, Hubli

At NeuMoD Digital PET-CT & Molecular Theranostics, Hubli, we prioritize:

Early appointments with no delays

Compassionate care for every patient

Accurate staging and monitoring for effective cancer management

Special regards to Dr. Rudresh Tabali Sir for timely referral and early diagnosis, which helped the patient receive appropriate therapy without delay.

Discussion

FDG PET-CT is increasingly recommended in initial staging of breast cancer, especially when advanced disease is suspected. Compared to conventional imaging, PET-CT offers:

Whole-body evaluation in a single sitting

Detection of both nodal and distant metastases

Accurate staging, which directly impacts treatment decisions

In this case, PET-CT identified lung and bone metastases that were not detected earlier, shifting the management strategy towards systemic therapy, ultimately benefiting the patient.

Conclusion

FDG PET-CT proved invaluable in the initial staging of breast cancer, identifying distant metastases and ensuring accurate treatment planning. This case reinforces the role of nuclear medicine and molecular imaging in comprehensive cancer care.